CanSino Biologics Inc.
HKEX:6185.HK
30.95 (HKD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|
Assets: | ||||||||
Current Assets: | ||||||||
Cash & Cash Equivalents
| 2,046.998 | 3,394.824 | 5,456.873 | 4,447.029 | 202.45 | 57.381 | 18.247 | 52.548 |
Short Term Investments
| 2,072.967 | 2,551.967 | 2,326.033 | 666.64 | 552.343 | 140 | 402.636 | 94 |
Cash and Short Term Investments
| 4,119.965 | 5,946.791 | 7,782.906 | 5,113.669 | 754.793 | 197.381 | 420.883 | 146.548 |
Net Receivables
| 636.882 | 855.49 | 157.926 | 22.143 | 17.899 | -135.547 | -266.77 | 0 |
Inventory
| 350.656 | 677.777 | 875.621 | 170.512 | 16.338 | 8.494 | 1.624 | 0 |
Other Current Assets
| 1,369.503 | 2,732.184 | 2,336.066 | 780.959 | 5.215 | 150.676 | 271.181 | 0.257 |
Total Current Assets
| 5,180.828 | 7,730.185 | 9,289.844 | 5,420.643 | 794.245 | 221.004 | 426.918 | 146.805 |
Non-Current Assets: | ||||||||
Property, Plant & Equipment, Net
| 3,040.348 | 3,083.144 | 2,218.305 | 881.914 | 589.694 | 507.449 | 396.894 | 158.179 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 205.647 | 258.739 | 198.305 | 72.297 | 57.215 | 51.256 | 40.764 | 19.756 |
Goodwill and Intangible Assets
| 205.647 | 258.739 | 198.305 | 72.297 | 57.215 | 51.256 | 40.764 | 19.756 |
Long Term Investments
| 446.556 | -2,501.852 | -2,280.723 | -401.199 | -245.475 | 0 | 0 | 0 |
Tax Assets
| 207.861 | 196.41 | 0 | 0 | 243.494 | 0 | 0 | 0 |
Other Non-Current Assets
| 237.529 | 2,702.334 | 2,448.456 | 774.418 | 345.325 | 16.166 | 1.788 | 1.433 |
Total Non-Current Assets
| 4,137.941 | 3,738.775 | 2,584.343 | 1,327.43 | 990.253 | 574.871 | 439.446 | 179.368 |
Total Assets
| 9,318.769 | 11,468.96 | 11,874.187 | 6,748.073 | 1,784.498 | 795.875 | 866.364 | 326.173 |
Liabilities & Equity: | ||||||||
Current Liabilities: | ||||||||
Account Payables
| 103.97 | 253.12 | 842.567 | 60.573 | 6.171 | 6.651 | 1.879 | 0.734 |
Short Term Debt
| 1,459.498 | 1,624.335 | 1,111.969 | 48.747 | 29.041 | 0.239 | 0.17 | 0 |
Tax Payables
| 0 | 23.719 | 34.535 | 1.159 | 0.49 | 0.233 | 0.438 | 0.063 |
Deferred Revenue
| -38.402 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 1,066.778 | 1,064.61 | 920.406 | 303.533 | 89.083 | 99.795 | 110.878 | 26.622 |
Total Current Liabilities
| 2,591.844 | 2,942.065 | 2,874.942 | 412.853 | 124.295 | 106.685 | 112.927 | 27.356 |
Non-Current Liabilities: | ||||||||
Long Term Debt
| 1,240.843 | 1,076.295 | 262.849 | 93.79 | 137.758 | 150 | 108.333 | 69.329 |
Deferred Revenue Non-Current
| 190.175 | 204.998 | 187.955 | 170.576 | 51.929 | 36.873 | 37.772 | 15.015 |
Deferred Tax Liabilities Non-Current
| -216.718 | 878.008 | 0.557 | 90 | 130 | -36.873 | -37.772 | -15.015 |
Other Non-Current Liabilities
| 225.21 | -878.008 | 0 | -90 | -130 | 36.873 | 37.772 | 15.015 |
Total Non-Current Liabilities
| 1,439.51 | 1,281.293 | 451.361 | 264.366 | 189.687 | 186.873 | 146.105 | 84.344 |
Total Liabilities
| 4,031.354 | 4,223.358 | 3,326.303 | 677.219 | 313.982 | 293.558 | 259.032 | 111.7 |
Equity: | ||||||||
Preferred Stock
| 118.389 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 247.45 | 247.45 | 247.45 | 247.45 | 222.65 | 160.951 | 156.444 | 0 |
Retained Earnings
| -1,558.414 | -75.682 | 1,031.309 | -764.692 | -368.054 | -211.288 | -73.007 | -136.085 |
Accumulated Other Comprehensive Income/Loss
| -0.176 | 0.121 | 0 | 0 | -0 | -36.074 | -25.742 | -17.668 |
Other Total Stockholders Equity
| 6,467.355 | 6,576.201 | 6,716.287 | 6,588.096 | 1,615.92 | 588.728 | 549.637 | 368.226 |
Total Shareholders Equity
| 5,274.604 | 6,748.09 | 7,995.046 | 6,070.854 | 1,470.516 | 502.317 | 607.332 | 214.473 |
Total Equity
| 5,287.415 | 7,245.602 | 8,547.884 | 6,070.854 | 1,470.516 | 502.317 | 607.332 | 214.473 |
Total Liabilities & Shareholders Equity
| 9,318.769 | 11,468.96 | 11,874.187 | 6,748.073 | 1,784.498 | 795.875 | 866.364 | 326.173 |